公司简介
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, ...
关联新闻
- Fulcrum to merge with Slate in all-stock deal after drug setback
Fulcrum Therapeutics said on Monday it would merge with privately held Slate Medicines in an all-stock deal, as the biotech looks to rebuild its pipeline after it discontinued development of its lea...